Cancer Vaccines Breakthrough: Moderna’s mRNA Tech Cuts Melanoma Recurrence by 50%
Think of conquering cancer, without that punishing side of chemotherapy, but instead a special personal injection. Such future is not as far as it seems. The trial shows the experimental mRNA cancer vaccines, Moderna, and Merck just cut melanoma recurrence rates by half. Still, this is not enough to take you off the ground? Then, Read details…